Lv5
1220 积分 2023-08-13 加入
Evolution of TROP2: Biological Insights and Clinical Applications
3个月前
已完结
Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay
4个月前
已关闭
FGF21 reverses MASH through coordinated actions on the CNS and liver
5个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
5个月前
已完结
Exploiting protease activation for therapy
11个月前
已完结
Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates
11个月前
已关闭
Antitumour actions of interferons: implications for cancer therapy
1年前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1年前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1年前
已完结
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
1年前
已完结
皖公网安备34019202002308
